Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - Role for Rho-kinase activation

British Journal of Pharmacology

Volumn 163, Issue 5, 2011, Pages 1059-1068

  Bagi, Zsolt ^a,d   Feher, Attila ^a,b   Cassuto, James ^a   Akula, Komala ^a   Labinskyy, Nazar ^a   Kaley, Gabor ^a   Koller, Akos ^a,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

arteriolar constriction; AT 1 receptor; diabetes mellitus; hyperglycaemia; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; GLUCOSE; RHO KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BIOAVAILABILITY; CELL LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLECULAR PATHOLOGY; MUSCLE BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMORAL ARTERY; RATS; RATS, ZUCKER; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RHO-ASSOCIATED KINASES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 79958828702     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01307.x     Document Type: Article

References (41)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Anborgh, PH, Seachrist, JL, Dale, LB, Ferguson, SS, (2000). Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Mol Endocrinol 14: 2040-2053.
3. Arun, KH, Kaul, CL, Ramarao, P, (2005). AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovasc Res 65: 374-386. (Pubitemid 40082479)
4. Bagi, Z, Koller, A, (2003). Lack of NO-mediation of flow-dependent arteriolar dilation in diabetes is restored by sepiapterin. J Vasc Res 40: 47-57. (Pubitemid 36351195)
5. Bagi, Z, Koller, A, Kaley, G, (2003). Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 285: H1404-H1410. (Pubitemid 37169492)
6. Bagi, Z, Koller, A, Kaley, G, (2004a). PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am J Physiol Heart Circ Physiol 286: H742-H748. (Pubitemid 38140357)
7. Bagi, Z, Toth, E, Koller, A, Kaley, G, (2004b). Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4). Am J Physiol Heart Circ Physiol 287: H626-H633. (Pubitemid 38955293)
8. Bagi, Z, Erdei, N, Toth, A, Li, W, Hintze, TH, Koller, A, et al,. (2005). Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 25: 1610-1616. (Pubitemid 41098929)
9. Bagi, Z, Erdei, N, Koller, A, (2008). High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors. Am J Physiol Heart Circ Physiol 295: H835-H841.
10. Cai, H, Harrison, DG, (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
11. Cooper ME, (2004). The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am J Hypertens 17: 16S-20S; quiz A12-14. (Pubitemid 39469911)
12. Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O, et al,. (2007). RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res 73: 190-197. (Pubitemid 44937192)
13. Galaria II, Fegley AJ, Nicholl SM, Roztocil E, Davies MG, (2004). Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res 122: 173-179. (Pubitemid 39535940)
14. Garcia PJ, Spellman CW, (2006). Should all diabetic patients receive statins? Curr Atheroscler Rep 8: 13-18. (Pubitemid 43675751)
15. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, et al,. (2005). COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735. (Pubitemid 41033368)
16. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK, (1997). Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11: 1266-1277. (Pubitemid 28041334)
17. Huang A, Koller A, (1997). Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Hypertension 30: 1210-1215. (Pubitemid 27476181)
18. Huang A, Sun D, Koller A, (1993). Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension 22: 913-921. (Pubitemid 23358100)
19. Hunyady L, Catt KJ, Clark AJ, Gaborik Z, (2000). Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept 91: 29-44.
20. Juul B, Aalkjaer C, Mulvany MJ, (1987). Responses of femoral resistance vessels to angiotensin in vitro. Eur J Pharmacol 135: 61-68. (Pubitemid 17051010)
21. Kizub IV, Pavlova OO, Johnson CD, Soloviev AI, Zholos AV, (2010). Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats. Br J Pharmacol 159: 1724-1731.
22. Koller A, Huang A, (1994). Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 74: 416-421. (Pubitemid 24064191)
23. Koller A, Huang A, (1999). Development of nitric oxide and prostaglandin mediation of shear stress-induced arteriolar dilation with aging and hypertension. Hypertension 34: 1073-1079.
24. Lee JH, Ragolia L, (2006). AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol 291: C1355-C1365. (Pubitemid 44878607)
25. Lefkowitz RJ, (1998). G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680. (Pubitemid 28366245)
26. Mathur G, Noronha B, Rodrigues E, Davis G, (2007). The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus. Diabetes Obes Metab 9: 617-629. (Pubitemid 47263388)
27. Mehta PK, Griendling KK, (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97. (Pubitemid 46127306)
28. Naik JS, Xiang L, Hester RL, (2006). Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290: R154-R161.
29. Nishimatsu H, Suzuki E, Satonaka H, Takeda R, Omata M, Fujita T, et al,. (2005). Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats. Am J Physiol Heart Circ Physiol 288: H1770-H1776. (Pubitemid 40418003)
30. Noma K, Oyama N, Liao JK, (2006). Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 290: C661-C668.
31. Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD, (2000). Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care 23: 888-892. (Pubitemid 30480013)
32. Rikitake Y, Liao JK, (2005). Rho GTPases, statins, and nitric oxide. Circ Res 97: 1232-1235.
33. Schmalzing G, Richter HP, Hansen A, Schwarz W, Just I, Aktories K, (1995). Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. J Cell Biol 130: 1319-1332.
34. Siddiqui AH, Hussain T, (2007). Enhanced AT1 receptor-mediated vasocontractile response to angiotensin II in endothelium-denuded aorta of obese Zucker rats. Am J Physiol Heart Circ Physiol 292: H1722-H1727. (Pubitemid 46572394)
35. Symons M, Rusk N, (2003). Control of vesicular trafficking by Rho GTPases. Curr Biol 13: R409-R418. (Pubitemid 36573246)
36. Thomas WG, Thekkumkara TJ, Baker KM, (1996). Molecular mechanisms of angiotensin II (AT1A) receptor endocytosis. Clin Exp Pharmacol Physiol Suppl 3: S74-S80. (Pubitemid 26421896)
37. Ungvari Z, Pacher P, Kecskemeti V, Papp G, Szollar L, Koller A, (1999). Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C. Cardiovasc Res 43: 1018-1028. (Pubitemid 29413860)
38. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A, (2004). Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 165: 219-226. (Pubitemid 38821829)
39. Vicaut E, Montalescot G, Hou X, Stucker O, Teisseire B, (1989). Arteriolar vasoconstriction and tachyphylaxis with intraarterial angiotensin II. Microvasc Res 37: 28-41. (Pubitemid 19045523)
40. Viswanad B, Srinivasan K, Kaul CL, Ramarao P, (2006). Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 53: 209-215. (Pubitemid 43247533)
41. Zhang C, Knudson JD, Setty S, Araiza A, Dincer UD, Kuo L, et al,. (2005). Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol 288: H2154-H2162. (Pubitemid 40604100)